Punit Dhillon's most recent trade in Skye Bioscience Inc was a trade of 650,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 31, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Skye Bioscience Inc | Punit Dhillon | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2026 | 650,000 | 650,000 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Punit Dhillon | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Mar 2026 | 650,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Punit Dhillon | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2026 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Punit Dhillon | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Mar 2026 | 250,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Punit Dhillon | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Mar 2026 | 125,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Punit Dhillon | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2026 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Punit Dhillon | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2026 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Punit Dhillon | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Mar 2026 | 36,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Punit Dhillon | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Mar 2026 | 21,586 | 0 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Punit Dhillon | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2026 | 21,586 | 21,586 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Punit Dhillon | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2026 | 12,360 | 12,360 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Punit Dhillon | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Mar 2026 | 12,360 | 0 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Punit Dhillon | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Mar 2026 | 9,013 | 0 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Punit Dhillon | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2026 | 9,013 | 9,013 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Punit Dhillon | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2026 | 280,000 | 280,000 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Punit Dhillon | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Punit Dhillon | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 4.99 per share. | 15 Nov 2024 | 82,546 | 329,823 (0%) | 0% | 5.0 | 411,905 | Common Stock |
| Skye Bioscience Inc | Punit Dhillon | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 5.55 per share. | 15 Nov 2024 | 364 | 412,369 (0%) | 0% | 5.5 | 2,020 | Common Stock |
| Skye Bioscience Inc | Punit Dhillon | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2024 | 650,000 | 650,000 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Punit Dhillon | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 26 Aug 2024 | 15,727 | 412,733 (0%) | 0% | - | Common Stock |